Previous Chapter Chapter 84: US Markets for Urological Devices Next Chapter
Chapter 84: US Markets for Urological Devices
In 2005, the US urological device market, comprising revenue from urinary incontinence (UI) devices, benign prostatic hyperplasia (BPH) treatment devices, stone management devices, prostate cancer devices, urological endoscopes, erectile dysfunction (ED) devices, ureteral access devices, and nephrostomy devices, was valued at over $1.6 billion. Among these, the markets for incontinence, BPH, [Page 770]ED, and ureteral access grew more rapidly than the overall urological device market. Demand for minimally invasive treatment options, positive clinical outcomes, and the introduction of new devices is driving growth in these market segments.
Growth in the US urological device market will, however, be hindered ...